Analytical Reports on Teva Pharmaceutical Industries Limited and Forest Laboratories Inc. - Drug Manufacturers Flexing Pipeli...
March 16 2012 - 8:25AM
Marketwired
www.SignalWatcher.com provides members with proprietary analysis of
over 10,000 stocks which is updated every day. Today, members can
receive their complimentary stock analysis on
Teva
Pharmaceutical Industries Limited (NASDAQ: TEVA) and
Forest Laboratories Inc. (NYSE: FRX). Sign up
now on www.SignalWatcher.com to get your free reports on these
stocks.
As patents for blockbuster drugs continue to expire, companies
in the Drug Manufacturers - Other industry have been working hard
to bring the next big product to market. Major players in the
industry have been working on treatments for a variety of ailments,
including major depressive disorder, cancer and a number of
others.
www.SignalWatcher.com brings investors free classic analysis on
Teva Pharmaceutical Industries Limited, Forest Laboratories Inc.
and other companies within the Drug Manufacturers - Other industry.
This type of analysis is only a fragment of the information members
have available to them. To learn more we encourage investors to
sign up at http://signalwatcher.com/EmailSignup.php.
Research and development costs remain high for the industry and
there are no guarantees that there will be any payoff. However,
several companies have been making solid progress. Forest
Laboratories Inc. together with Pierre Fabre Medicament recently
stated they had successfully completed two positive Phase III
studies of their levomilnacipran offing, an investigational agent
used for the treatment of major depressive disorder in adults.
www.SignalWatcher.com gives traders a unique insight about
Forest Laboratories Inc. by registering now
at http://signalwatcher.com/FRX/March162012.php.
On the other hand, Teva Pharmaceuticals Industries Limited has
also been busy recently, with its Teva UK subsidiary announcing
that it has released a generic alternative to GlaxoSmithKline UK's
Naramig®, which is used in the treatment of migraine headaches.
www.SignalWatcher.com gives traders a unique insight about
Teva Pharmaceutical Industries Limited by
registering now at
http://signalwatcher.com/TEVA/March162012.php.
About Signal Watch
Signal Watch's #1 goal is to help customers successfully engage
the markets. For over 20 years, we have been developing the most
powerful trading software available anywhere. But the software is
only part of our mission. We also provide education and customer
support designed to enable our customers to take control of their
financial future.
Read our disclaimer by clicking on the following link
http://www.signalwatcher.com/disclaimers.php.
For More Information Contact: Eric Avalos Marketing
Advisor info@signalwatcher.com
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Aug 2023 to Aug 2024